Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 475

1.

miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery.

Kresoja-Rakic J, Szpechcinski A, Kirschner MB, Ronner M, Minatel B, Martinez VD, Lam WL, Weder W, Stahel R, Früh M, Cerciello F, Felley-Bosco E.

Noncoding RNA. 2019 Jun 17;5(2). pii: E41. doi: 10.3390/ncrna5020041.

PMID:
31212997
2.

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.

Kerr KM, Thunnissen E, Dafni U, Finn SP, Bubendorf L, Soltermann A, Verbeken E, Biernat W, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Radonic T, Wilson J, De Luca G, Gray SG, Cheney R, Savic S, Martorell M, Muley T, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dziadziuszko R, Vansteenkiste J, Weder W, Polydoropoulou V, Geiger T, Kammler R, Peters S, Stahel R; Lungscape Consortium.

Lung Cancer. 2019 May;131:95-103. doi: 10.1016/j.lungcan.2019.03.012. Epub 2019 Mar 15.

PMID:
31027705
3.

Applicability of color-coded computed tomography images in lung volume reduction surgery planning.

Muehlematter UJ, Caviezel C, Martini K, Messerli M, Vokinger KN, Wetzler IR, Tutic-Horn M, Weder W, Frauenfelder T.

J Thorac Dis. 2019 Mar;11(3):766-776. doi: 10.21037/jtd.2019.02.36.

4.

Establishing a non-intubated thoracoscopic surgery programme for bilateral uniportal sympathectomy.

Caviezel C, Schuepbach R, Grande B, Opitz I, Zalunardo M, Weder W, Hillinger S.

Swiss Med Wkly. 2019 Apr 17;149:w20064. doi: 10.4414/smw.2019.20064. eCollection 2019 Apr 8.

5.

Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).

Curioni-Fontecedro A, Perentes JY, Gelpke H, Xyrafas A, Bouchaab H, Mach N, Matzinger O, Stojcheva N, Frueh M, Weder W, Cathomas R, Gargiulo P, Bubendorf L, Pless M, Betticher D, Peters S; Swiss Group of Clinical Cancer Research (SAKK).

Br J Cancer. 2019 May;120(10):968-974. doi: 10.1038/s41416-019-0447-0. Epub 2019 Apr 16.

PMID:
30988393
6.

Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis.

van Geffen WH, Slebos DJ, Herth FJ, Kemp SV, Weder W, Shah PL.

Lancet Respir Med. 2019 Apr;7(4):313-324. doi: 10.1016/S2213-2600(18)30431-4. Epub 2019 Feb 8.

PMID:
30744937
7.

The Amide Local Anesthetic Ropivacaine Attenuates Acute Rejection After Allogeneic Mouse Lung Transplantation.

Maeyashiki T, Jang JH, Janker F, Yamada Y, Inci I, Weder W, Piegeler T, Jungraithmayr W.

Lung. 2019 Apr;197(2):217-226. doi: 10.1007/s00408-019-00197-5. Epub 2019 Feb 9.

PMID:
30739218
8.

The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.

Jang JH, Janker F, De Meester I, Arni S, Borgeaud N, Yamada Y, Gil Bazo I, Weder W, Jungraithmayr W.

Carcinogenesis. 2019 Apr 29;40(2):324-334. doi: 10.1093/carcin/bgz009.

PMID:
30698677
9.

Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours.

Ruffini E, Guerrera F, Brunelli A, Passani S, Pellicano D, Thomas P, Van Raemdonck D, Rocco G, Venuta F, Weder W, Detterbeck F, Falcoz PE.

Eur J Cardiothorac Surg. 2019 Apr 1;55(4):601-609. doi: 10.1093/ejcts/ezy448.

PMID:
30649256
10.

Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network.

Román M, López I, Guruceaga E, Baraibar I, Ecay M, Collantes M, Nadal E, Vallejo A, Cadenas S, Miguel ME, Jang JH, Martin-Uriz PS, Castro-Labrador L, Vilas-Zornoza A, Lara-Astiaso D, Ponz-Sarvise M, Rolfo C, Santos ES, Raez LE, Taverna S, Behrens C, Weder W, Wistuba II, Vicent S, Gil-Bazo I.

Cancer Res. 2019 Feb 1;79(3):625-638. doi: 10.1158/0008-5472.CAN-18-1479. Epub 2018 Dec 18.

PMID:
30563891
11.

The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.

Guckenberger M, Aerts JG, Van Schil P, Weder W.

J Thorac Cardiovasc Surg. 2019 Jan;157(1):358-361. doi: 10.1016/j.jtcvs.2018.09.107. Epub 2018 Oct 12. No abstract available. Erratum in: J Thorac Cardiovasc Surg. 2019 Mar 25;:.

PMID:
30557952
12.

Nonintubated surgical biopsy of undetermined interstitial lung disease: a multicentre outcome analysis.

Pompeo E, Rogliani P, Atinkaya C, Guerrera F, Ruffini E, Iñiguez-Garcia MA, Peer M, Voltolini L, Caviezel C, Weder W, Opitz I, Cavalli F, Sorge R.

Interact Cardiovasc Thorac Surg. 2018 Dec 1. doi: 10.1093/icvts/ivy320. [Epub ahead of print]

PMID:
30508104
13.

Intraluminal EWSR1-CREB1 gene rearranged, low-grade myxoid sarcoma of the pulmonary artery resembling extraskeletal myxoid chondrosarcoma (EMC).

Opitz I, Lauk O, Schneiter D, Ulrich S, Maisano F, Weder W, Bode-Lesniewska B.

Histopathology. 2019 Feb;74(3):526-530. doi: 10.1111/his.13773. Epub 2018 Dec 5. No abstract available.

PMID:
30326150
14.

Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01).

Früh M, Betticher DC, Stupp R, Xyrafas A, Peters S, Ris HB, Mirimanoff RO, Ochsenbein AF, Schmid R, Matzinger O, Stahel RA, Weder W, Guckenberger M, Rothschild SI, Lardinois D, Mach N, Mark M, Gautschi O, Thierstein S, Biaggi Rudolf C, Pless M; Swiss Group for Clinical Cancer Research (SAKK).

J Thorac Oncol. 2019 Jan;14(1):115-123. doi: 10.1016/j.jtho.2018.09.011. Epub 2018 Sep 26.

PMID:
30267838
15.

Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort.

Rulle U, Tsourti Z, Casanova R, Deml KF, Verbeken E, Thunnissen E, Warth A, Cheney R, Sejda A, Speel EJ, Madsen LB, Nonaka D, Navarro A, Sansano I, Marchetti A, Finn SP, Monkhorst K, Kerr KM, Haberecker M, Wu C, Zygoura P, Kammler R, Geiger T, Gendreau S, Schulze K, Vrugt B, Wild P, Moch H, Weder W, Ciftlik AT, Dafni U, Peters S, Bubendorf L, Stahel RA, Soltermann A.

J Thorac Oncol. 2018 Dec;13(12):1851-1863. doi: 10.1016/j.jtho.2018.08.2034. Epub 2018 Sep 18.

16.

Postoperative complications and management after lung volume reduction surgery.

Lacour M, Caviezel C, Weder W, Schneiter D.

J Thorac Dis. 2018 Aug;10(Suppl 23):S2775-S2779. doi: 10.21037/jtd.2018.08.75. Review.

17.

Lung volume reduction surgery beyond the NETT selection criteria.

Caviezel C, Schneiter D, Opitz I, Weder W.

J Thorac Dis. 2018 Aug;10(Suppl 23):S2748-S2753. doi: 10.21037/jtd.2018.08.93. Review.

18.

Improved postoperative lung function after sublobar resection of non-small-cell lung cancer combined with lung volume reduction surgery in patients with advanced emphysema.

Caviezel C, von Rotz J, Schneiter D, Inci I, Hillinger S, Opitz I, Weder W.

J Thorac Dis. 2018 Aug;10(Suppl 23):S2704-S2710. doi: 10.21037/jtd.2018.06.79.

19.

Lung volume reduction-a great chance for emphysema patients!

Franzen DP, Weder W.

J Thorac Dis. 2018 Aug;10(Suppl 23):S2696-S2697. doi: 10.21037/jtd.2018.04.144. No abstract available.

20.

Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients.

Tallón de Lara P, Cecconi V, Hiltbrunner S, Yagita H, Friess M, Bode B, Opitz I, Vrugt B, Weder W, Stolzmann P, Felley-Bosco E, Stahel RA, Tischler V, Britschgi C, Soldini D, van den Broek M, Curioni-Fontecedro A.

Clin Cancer Res. 2018 Dec 15;24(24):6345-6354. doi: 10.1158/1078-0432.CCR-18-1231. Epub 2018 Aug 28.

PMID:
30154226
21.

Dynamic magnetic resonance imaging as an outcome predictor for lung-volume reduction surgery in patients with severe emphysema.

Martini K, Caviezel C, Schneiter D, Milanese G, Opitz I, Weder W, Frauenfelder T.

Eur J Cardiothorac Surg. 2018 Aug 13. doi: 10.1093/ejcts/ezy277. [Epub ahead of print]

PMID:
30124803
22.

Preclinical, non-genetic models of lung adenocarcinoma: a comparative survey.

Janker F, Weder W, Jang JH, Jungraithmayr W.

Oncotarget. 2018 Jul 17;9(55):30527-30538. doi: 10.18632/oncotarget.25668. eCollection 2018 Jul 17.

23.

Lung Transplantation with Controlled Donation after Circulatory Death Donors.

Inci I, Hillinger S, Schneiter D, Opitz I, Schuurmans M, Benden C, Weder W.

Ann Thorac Cardiovasc Surg. 2018 Dec 20;24(6):296-302. doi: 10.5761/atcs.oa.18-00098. Epub 2018 Jul 2.

24.

Pleural mesothelioma: is the surgeon still there?

Opitz I, Weder W.

Ann Oncol. 2018 Aug 1;29(8):1710-1717. doi: 10.1093/annonc/mdy195.

PMID:
29905765
25.

Early and late abdominal surgeries after lung transplantation: incidence and outcome.

Sulser P, Lehmann K, Schuurmans MM, Weder W, Inci I.

Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):727-732. doi: 10.1093/icvts/ivy172.

PMID:
29846608
26.

Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice.

Gulati P, Rühl J, Kannan A, Pircher M, Schuberth P, Nytko KJ, Pruschy M, Sulser S, Haefner M, Jensen S, Soltermann A, Jungraithmayr W, Eisenring M, Winder T, Samaras P, Tabor A, Stenger R, Stupp R, Weder W, Renner C, Münz C, Petrausch U.

Clin Cancer Res. 2018 Aug 15;24(16):3981-3993. doi: 10.1158/1078-0432.CCR-17-1788. Epub 2018 May 10.

PMID:
29748183
27.

Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation.

Cottini SR, Brandi G, Pagnamenta A, Weder W, Schuepbach RA, Béchir M, Huber LC, Benden C.

Clin Transplant. 2018 May;32(5):e13251. doi: 10.1111/ctr.13251. Epub 2018 Apr 30.

PMID:
29707826
28.

Urokinase application for hemothorax in pulmonary mucormycosis.

Hodel L, Inci I, Schanz U, Vrugt B, Weder W, Hillinger S.

J Thorac Dis. 2018 Mar;10(3):E175-E178. doi: 10.21037/jtd.2018.03.01.

29.

Antwort.

Weder W.

Pneumologie. 2018 Apr;72(4):321. doi: 10.1055/a-0586-6496. Epub 2018 Apr 11. German. No abstract available.

PMID:
29642250
30.

Lung volume reduction surgery in selected patients with emphysema and pulmonary hypertension.

Caviezel C, Aruldas C, Franzen D, Ulrich S, Inci I, Schneiter D, Weder W, Opitz I.

Eur J Cardiothorac Surg. 2018 Sep 1;54(3):565-571. doi: 10.1093/ejcts/ezy092.

PMID:
29538689
31.

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.

George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, Maas L, Müller C, Dahmen I, Delhomme TM, Ardin M, Leblay N, Byrnes G, Sun R, De Reynies A, McLeer-Florin A, Bosco G, Malchers F, Menon R, Altmüller J, Becker C, Nürnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soloway MG, Wilkerson MD, Cun Y, McKay JD, Moro-Sibilot D, Brambilla CG, Lantuejoul S, Lemaitre N, Soltermann A, Weder W, Tischler V, Brustugun OT, Lund-Iversen M, Helland Å, Solberg S, Ansén S, Wright G, Solomon B, Roz L, Pastorino U, Petersen I, Clement JH, Sänger J, Wolf J, Vingron M, Zander T, Perner S, Travis WD, Haas SA, Olivier M, Foll M, Büttner R, Hayes DN, Brambilla E, Fernandez-Cuesta L, Thomas RK.

Nat Commun. 2018 Mar 13;9(1):1048. doi: 10.1038/s41467-018-03099-x.

32.

Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression.

Oehl K, Kresoja-Rakic J, Opitz I, Vrugt B, Weder W, Stahel R, Wild P, Felley-Bosco E.

Front Oncol. 2018 Feb 23;8:40. doi: 10.3389/fonc.2018.00040. eCollection 2018.

33.

Influence of inter-observer delineation variability on radiomics stability in different tumor sites.

Pavic M, Bogowicz M, Würms X, Glatz S, Finazzi T, Riesterer O, Roesch J, Rudofsky L, Friess M, Veit-Haibach P, Huellner M, Opitz I, Weder W, Frauenfelder T, Guckenberger M, Tanadini-Lang S.

Acta Oncol. 2018 Aug;57(8):1070-1074. doi: 10.1080/0284186X.2018.1445283. Epub 2018 Mar 7.

PMID:
29513054
34.

Computationally-Guided Development of a Stromal Inflammation Histologic Biomarker in Lung Squamous Cell Carcinoma.

Xia D, Casanova R, Machiraju D, McKee TD, Weder W, Beck AH, Soltermann A.

Sci Rep. 2018 Mar 2;8(1):3941. doi: 10.1038/s41598-018-22254-4.

35.

A strategy to analyse activity-based profiling of tyrosine kinase substrates in OCT-embedded lung cancer tissue.

Arni S, de Wijn R, Garcia-Villegas R, Bitanihirwe BKY, Caviezel C, Weder W, Hillinger S.

Anal Biochem. 2018 Apr 15;547:77-83. doi: 10.1016/j.ab.2018.02.001. Epub 2018 Feb 22.

PMID:
29408474
36.

What's happening next.

Rocco G, Weder W.

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1781-1782. doi: 10.1016/j.jtcvs.2017.12.060. Epub 2017 Dec 23. No abstract available.

PMID:
29395199
37.

Extracorporeal photopheresis as second-line treatment therapy in life-threatening primary graft dysfunction following lung transplantation.

Robinson CA, Inci I, Naegeli M, Murer C, Schuurmans MM, Urosevic-Maiwald M, Schüpbach R, Weder W, Benden C.

Pediatr Transplant. 2018 May;22(3):e13145. doi: 10.1111/petr.13145. Epub 2018 Jan 29.

PMID:
29380491
38.

[Lung Volume Reduction Surgery].

Caviezel C, Franzen D, Weder W.

Pneumologie. 2018 Jan;72(1):64-78. doi: 10.1055/s-0043-103363. Epub 2018 Jan 16. Review. German.

PMID:
29341033
39.

The great debate flashes: surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.

Weder W, Moghanaki D, Stiles B, Siva S, Rocco G.

Eur J Cardiothorac Surg. 2018 Feb 1;53(2):295-305. doi: 10.1093/ejcts/ezx410.

PMID:
29309549
40.

Impact of human leukocyte antigen mismatch on lung transplant outcome.

Yamada Y, Langner T, Inci I, Benden C, Schuurmans M, Weder W, Jungraithmayr W.

Interact Cardiovasc Thorac Surg. 2018 May 1;26(5):859-864. doi: 10.1093/icvts/ivx412.

PMID:
29300898
41.

Outcome After Lung Volume Reduction Surgery in Patients With Severely Impaired Diffusion Capacity.

Caviezel C, Schaffter N, Schneiter D, Franzen D, Inci I, Opitz I, Weder W.

Ann Thorac Surg. 2018 Feb;105(2):379-385. doi: 10.1016/j.athoracsur.2017.09.006. Epub 2017 Dec 7.

PMID:
29223424
42.

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

Letovanec I, Finn S, Zygoura P, Smyth P, Soltermann A, Bubendorf L, Speel EJ, Marchetti A, Nonaka D, Monkhorst K, Hager H, Martorell M, Sejda A, Cheney R, Hernandez-Losa J, Verbeken E, Weder W, Savic S, Di Lorito A, Navarro A, Felip E, Warth A, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dienemann H, Dziadziuszko R, Vansteenkiste J, O'Brien C, Geiger T, Sherlock J, Schageman J, Dafni U, Kammler R, Kerr K, Thunnissen E, Stahel R, Peters S; European Thoracic Oncology Platform Lungscape Consortium.

J Thorac Oncol. 2018 Mar;13(3):413-425. doi: 10.1016/j.jtho.2017.11.117. Epub 2017 Nov 27.

43.

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.

Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S; ETOP Lungscape Consortium.

Ann Oncol. 2018 Jan 1;29(1):200-208. doi: 10.1093/annonc/mdx629.

PMID:
29186353
44.

Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.

Klikovits T, Stockhammer P, Laszlo V, Dong Y, Hoda MA, Ghanim B, Opitz I, Frauenfelder T, Nguyen-Kim TDL, Weder W, Berger W, Grusch M, Aigner C, Klepetko W, Dome B, Renyi-Vamos F, Oehler R, Hegedus B.

Sci Rep. 2017 Nov 28;7(1):16456. doi: 10.1038/s41598-017-16551-7.

45.

Single-center experience with intraoperative extracorporeal membrane oxygenation use in lung transplantation.

Cosgun T, Tomaszek S, Opitz I, Wilhelm M, Schuurmans MM, Weder W, Inci I.

Int J Artif Organs. 2017 Oct 9:0. doi: 10.5301/IJAO.5000645. [Epub ahead of print]

PMID:
29027193
46.

Ex vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation.

Yamada Y, Iskender I, Arni S, Hillinger S, Cosgun T, Yu K, Jungraithmayr W, Cesarovic N, Weder W, Inci I.

J Surg Res. 2017 Oct;218:341-347. doi: 10.1016/j.jss.2017.06.061. Epub 2017 Jul 22.

PMID:
28985871
47.

Ex vivo multiplex profiling of protein tyrosine kinase activities in early stages of human lung adenocarcinoma.

Arni S, Le THN, de Wijn R, Garcia-Villegas R, Dankers M, Weder W, Hillinger S.

Oncotarget. 2017 Aug 2;8(40):68599-68613. doi: 10.18632/oncotarget.19803. eCollection 2017 Sep 15.

48.

Previous lung volume reduction surgery does not negatively affect survival after lung transplantation.

Inci I, Iskender I, Ehrsam J, Caviezel C, Hillinger S, Opitz I, Schneiter D, Weder W.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):596-602. doi: 10.1093/ejcts/ezx318.

PMID:
28957998
49.

Ex vivo administration of trimetazidine improves post-transplant lung function in pig model.

Cosgun T, Iskender I, Yamada Y, Arni S, Lipiski M, van Tilburg K, Weder W, Inci I.

Eur J Cardiothorac Surg. 2017 Jul 1;52(1):171-177. doi: 10.1093/ejcts/ezx053.

PMID:
28874022
50.

Acute pulmonary embolism and multiple pulmonary nodules mimicking metastatic disease.

Brüstle K, Zachariassen K, Vrugt B, Frauenfelder T, Weder W, Franzen D.

Thorax. 2018 Feb;73(2):193-194. doi: 10.1136/thoraxjnl-2017-210435. Epub 2017 Aug 31. No abstract available.

PMID:
28860334

Supplemental Content

Support Center